Design of fine particles for pulmonary drug delivery.
Particle design for inhalation is characterized by advances in particle processing methods and the utilization of new excipients. Processing methods such as spray drying allow control over critical particle design features, such as particle size and distribution, surface energy, surface rugosity, particle density, surface area, porosity and microviscosity. Control of these features has enabled new classes of therapeutics to be delivered by inhalation. These include therapeutics that have a narrow therapeutic index, require a high delivered dose, and/or elicit their action systemically. Engineered particles are also being utilized for immune modulation, with exciting advances being made in the delivery of antibodies and inhaled vaccines. Continued advances are expected to result in 'smart' therapeutics capable of active targeting and intracellular trafficking.
Weers
Jeffry G
JG
Nektar Therapeutics, 150 Industrial Road, San Carlos, CA 94070, USA. jweers@ca.nektar.com
Tarara
Thomas E
TE
Clark
Andrew R
AR
D000280:Administration, Inhalation; D000818:Animals; D000906:Antibodies / Q000627:therapeutic use; D004339:Drug Compounding; D016503:Drug Delivery Systems; D006801:Humans; D010316:Particle Size; D010455:Peptides / Q000008:administration & dosage; D016062:Porosity; D011208:Powders; D011506:Proteins / Q000008:administration & dosage; D014611:Vaccination
D000906:Antibodies; D010455:Peptides; D011208:Powders; D011506:Proteins